Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act

Overview of attention for article published in Critical Care, August 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,468 followers.

Open Access UCL Research: Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act https://t.co/WUroUYv3kV

A letter we wrote in regards to an excellent clinical trial published in @Crit_Care https://t.co/EQLHjV6KXT

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.